Vascular dementia is a type of dementia that happens when the blood supply to your brain becomes reduced. It is a common type of dementia that can caused by a single stroke, a series of small, silent strokes or small vessels disease.
Cerebral venous thrombosis (CVT) is an unusual form of stroke. It is little researched largely because it accounts for less than 1% of all strokes. The study will provide a much better understanding for the reasons underlying CVT, which is an unusual but very important cause of stroke in young (mainly female) adults.
A new study published in the journal PLOS Medicine suggests that being diagnosed with shingles could increase the risk of stroke, and heart attack, for some months after diagnosis. The study was co-funded by the Stroke Association.
Cholesterol is a fatty substance that is found in our blood. Reducing your cholesterol level can reduce your risk of stroke.
The Stroke Association is a member of the Association of Medical Research Charities (AMRC). Published today, the AMRC have launched a new booklet outling highlighting how vital health information is to enable researchers to prevent, diagnose and treat disease and improve care.
The Cross-Party Group (CPG) on Heart Disease and Stroke in the Scottish Parliament held an Inquiry into high blood pressure in Scotland. There are a set of recommendations in the report that will be published on Tuesday 22 January 2019.
After a stroke some people have difficulty swallowing (dysphagia). This can cause a serious chest infection known as Stroke Associated Pneumonia (SAP). Published in the journal Cerebrovascular Diseases, a new systematic review of the evidence sheds light on the issue.
Dementia is caused when the brain is damaged by disease or injury. This causes the structure of the brain to change, leading to the loss of some brain cells.
In January, NHS England announced their Long Term Plan, in which stroke has been named as a new national priority. It also includes sections on both stroke care as well as cardiovascular disease.
Funded by the European Union (EU), a new international study called PROOF will investigate whether high-dose oxygen therapy can reduce the effects of stroke.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE), which will work on communication of information about the PROOF trial to non-clinical audiences.